ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 229 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2019. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $16,997 | -32.7% | 1,349 | -30.2% | 0.00% | – |
| Q1 2023 | $25,239 | +21.5% | 1,934 | +64.2% | 0.00% | – |
| Q4 2022 | $20,780 | -9.7% | 1,178 | -20.9% | 0.00% | – |
| Q3 2022 | $23,000 | -30.3% | 1,490 | -33.9% | 0.00% | – |
| Q2 2022 | $33,000 | -99.3% | 2,254 | -99.0% | 0.00% | -100.0% |
| Q1 2022 | $4,905,000 | -10.3% | 217,828 | -26.5% | 0.01% | +10.0% |
| Q4 2021 | $5,467,000 | +65.7% | 296,309 | +20.0% | 0.01% | +66.7% |
| Q3 2021 | $3,300,000 | +109900.0% | 246,857 | +165575.8% | 0.01% | – |
| Q2 2021 | $3,000 | +50.0% | 149 | +31.9% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 113 | +98.2% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 57 | -31.3% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 83 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | -99.8% | 83 | -99.9% | 0.00% | -100.0% |
| Q1 2020 | $518,000 | -41.1% | 73,676 | -17.8% | 0.00% | 0.0% |
| Q4 2019 | $880,000 | -23.7% | 89,668 | -14.7% | 0.00% | -33.3% |
| Q3 2019 | $1,154,000 | +47.8% | 105,124 | +56.4% | 0.00% | +50.0% |
| Q2 2019 | $781,000 | -27.2% | 67,229 | -40.3% | 0.00% | -33.3% |
| Q1 2019 | $1,073,000 | -21.0% | 112,523 | -20.2% | 0.00% | -25.0% |
| Q4 2018 | $1,359,000 | -50.5% | 141,008 | -26.9% | 0.00% | -33.3% |
| Q3 2018 | $2,747,000 | -8.0% | 192,783 | -22.5% | 0.01% | -33.3% |
| Q2 2018 | $2,985,000 | -47.2% | 248,716 | -45.7% | 0.01% | -43.8% |
| Q1 2018 | $5,656,000 | +328.8% | 457,961 | +404.9% | 0.02% | +300.0% |
| Q4 2017 | $1,319,000 | +6.0% | 90,708 | +3.8% | 0.00% | 0.0% |
| Q3 2017 | $1,244,000 | +3.6% | 87,407 | -7.1% | 0.00% | +33.3% |
| Q2 2017 | $1,201,000 | -3.8% | 94,085 | -4.4% | 0.00% | -25.0% |
| Q1 2017 | $1,248,000 | -12.0% | 98,461 | -29.1% | 0.00% | 0.0% |
| Q4 2016 | $1,418,000 | -19.2% | 138,906 | +4.3% | 0.00% | -20.0% |
| Q3 2016 | $1,755,000 | +0.1% | 133,181 | -3.5% | 0.01% | 0.0% |
| Q2 2016 | $1,753,000 | -2.1% | 137,983 | +1.9% | 0.01% | -16.7% |
| Q1 2016 | $1,790,000 | +16.0% | 135,440 | +35.0% | 0.01% | +20.0% |
| Q4 2015 | $1,543,000 | +8.2% | 100,330 | -12.7% | 0.01% | 0.0% |
| Q3 2015 | $1,426,000 | -7.9% | 114,969 | +1.5% | 0.01% | 0.0% |
| Q2 2015 | $1,549,000 | +12.3% | 113,249 | -1.8% | 0.01% | +25.0% |
| Q1 2015 | $1,379,000 | -3.4% | 115,282 | +3.1% | 0.00% | 0.0% |
| Q4 2014 | $1,428,000 | -7.8% | 111,822 | -3.2% | 0.00% | -20.0% |
| Q3 2014 | $1,549,000 | +42.8% | 115,466 | +70.7% | 0.01% | +66.7% |
| Q2 2014 | $1,085,000 | -22.2% | 67,624 | -12.5% | 0.00% | -40.0% |
| Q1 2014 | $1,394,000 | -33.5% | 77,300 | -43.0% | 0.01% | -28.6% |
| Q4 2013 | $2,096,000 | +91.9% | 135,601 | +84.6% | 0.01% | +75.0% |
| Q3 2013 | $1,092,000 | +1.5% | 73,467 | -11.6% | 0.00% | 0.0% |
| Q2 2013 | $1,076,000 | – | 83,119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |